ID: ALA4126629
Chembl Id: CHEMBL4126629
PubChem CID: 145963588
Max Phase: Preclinical
Molecular Formula: C26H30ClN7O2
Molecular Weight: 508.03
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CN(C)/N=C1/CN(CC(=O)Nc2cccc(-c3cnn(C)c3)c2)C(=O)C(Cc2ccccc2Cl)CN1
Standard InChI: InChI=1S/C26H30ClN7O2/c1-32(2)31-24-16-34(26(36)20(13-28-24)11-19-7-4-5-10-23(19)27)17-25(35)30-22-9-6-8-18(12-22)21-14-29-33(3)15-21/h4-10,12,14-15,20H,11,13,16-17H2,1-3H3,(H,28,31)(H,30,35)
Standard InChI Key: KVTQCHZUXQFQGP-UHFFFAOYSA-N
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Molecular Weight: 508.03 | Molecular Weight (Monoisotopic): 507.2150 | AlogP: 2.84 | #Rotatable Bonds: 7 |
| Polar Surface Area: 94.86 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 2 |
| #RO5 Violations: 1 | HBA (Lipinski): 9 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
| CX Acidic pKa: 13.32 | CX Basic pKa: 7.46 | CX LogP: 1.96 | CX LogD: 1.63 |
| Aromatic Rings: 3 | Heavy Atoms: 36 | QED Weighted: 0.48 | Np Likeness Score: -1.55 |
| 1. Murafuji H, Sugawara H, Goto M, Oyama Y, Sakai H, Imajo S, Tomoo T, Muto T.. (2018) Structure-based drug design to overcome species differences in kallikrein 7 inhibition of 1,3,6-trisubstituted 1,4-diazepan-7-ones., 26 (12): [PMID:29884582] [10.1016/j.bmc.2018.05.044] |
Source(1):
